Cours Infant Bacterial Therapeutics AB (publ) Other OTC
Actions
Produits pharmaceutiques
CA 2022 | - | CA 2023 | 0,08 0,07 | Capitalisation | 1,21 Md 1,09 Md |
---|---|---|---|---|---|
Résultat net 2022 | -65 M -58,21 M | Résultat net 2023 | -123 M -110 M | VE / CA 2022 | - |
Trésorerie nette 2022 | 336 M 301 M | Trésorerie nette 2023 | 329 M 295 M | VE / CA 2023 | 11 472 257 143 x |
PER 2022 |
-8,58
x | PER 2023 |
-9,04
x | Employés | - |
Rendement 2022 * |
-
| Rendement 2023 |
-
| Flottant | 87,87% |
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Chief Executive Officer | 57 | 01/01/13 | |
Maria Ekdahl
DFI | Director of Finance/CFO | 51 | 19/09/22 |
Chief Operating Officer | 57 | 20/10/14 |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Margareta Hagman
BRD | Director/Board Member | 58 | 24/09/15 |
Chairman | 74 | 01/01/11 | |
Anthon Jahreskog
BRD | Director/Board Member | 44 | 04/05/17 |
Varia. 1 janv. | Capi. | |
---|---|---|
+18,88% | 80,5 Md | |
+14,11% | 9,15 Md | |
-14,14% | 4,9 Md | |
+43,39% | 4,49 Md | |
+18,90% | 4,44 Md | |
+7,93% | 2,19 Md | |
-28,40% | 2,13 Md | |
+15,93% | 2,1 Md | |
-43,17% | 1,78 Md |